Details of the Drug
General Information of Drug (ID: DMMFWYX)
| Drug Name |
6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL291461; 6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione; 72255-49-3; 2,4(1H,3H)-Pyrimidinedione, 6-[(3-bromophenyl)amino]-; 6-[(3-bromophenyl)amino]pyrimidine-2,4(1H,3H)-dione; AC1LFXXC; Oprea1_136416; Oprea1_839686; MLS000713738; CTK2H2676; DTXSID30355636; MolPort-001-933-580; ZINC322347; HMS3363I15; HMS2635L06; HMS1673K06; BDBM50028343; STK385018; AKOS000541603; MCULE-5935337788; SMR000273219; BAS 00450422; ST50002707; 6-(3-bromoanilino)-1H-pyrimidine-2,4-dione; AB00091424-01
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 282.09 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.5 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


